 |
|
|
2014 Press/Media Releases: OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints Rayaldee™ Phase 3 Trial Meets Primary Endpoints OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE™ OPKO Completes Patient Enrollment in Third Phase 3 Trial of RAYALDEE™ OPKO Health Announces Key Executive Appointments for Renal Division |
© 2023 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use |